Moderna could have to wait until as late as December to analyse data from its Covid-19 vaccine trial, longer than would be necessary to meet the Trump administration’s hopes of issuing an emergency approval ahead of the US election.
Moderna可能最遲要等到12月才能分析其新型冠狀病毒肺炎（COVID-19，即2019冠狀病毒病）疫苗試驗的數據，這比希望在美國大選之前發佈緊急批准的川普政府期待的速度要慢。
您已閱讀8%（323字），剩餘92%（3787字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。